Prescription peptide medicines
Approved for specific products, doses, routes and medical uses after FDA review. Approval never means that every person—or every advertised use—is appropriate.
Review approved therapiesHome / Peptides / Clinical Peptide Therapy
Physician-crafted · medically managed · made understandableClinical peptide therapy,
without the guesswork.
Peptides are not one treatment and they are not a shortcut. We start with your health, your symptoms and your goals—then a physician-led team determines whether an evidence-based peptide medicine belongs in your plan.
Ageless AI Before & After Experience
See Your Future Self after therapy.
Turn your health goals into something you can see. Create an AI-generated visualization to help imagine your future, clarify what motivates you and begin a more meaningful conversation with our clinical team.
The Ageless preview opens in a new tab and is operated by a third party. Review its displayed privacy information before uploading a photograph or personal information.
Peptides for Real Life
What is a peptide—in plain English?
A peptide is a short chain of amino acids. Your body uses many peptides as messengers, telling cells when to do things such as release insulin, regulate appetite or carry out other specific functions. A peptide-based medicine is designed to act on a defined biological pathway. The right question is not “Which peptide is trending?” It is “Is there a well-supported medicine for my diagnosis, and is it safe for me?”
SignalA peptide can carry a message to a receptor.
ResponseThe body may change a specific process, such as appetite signaling.
SupervisionYour response and adverse effects require clinical follow-up.
Three Very Different Buckets
“Peptide” does not automatically mean proven or appropriate.
We discuss product status openly before a treatment decision.
Compounded medication
Compounded drugs are not FDA-approved. They may be considered only when an individualized medical need cannot be met by an available FDA-approved product and applicable law permits.
See our sourcing standardsInvestigational or research-only
A vial labeled “research use only” is not a patient treatment. Retatrutide remains investigational; the FDA says it cannot be used in compounding under federal law.
Understand research statusChoose Your Starting Point
One clinical standard. Two tailored conversations.
Women and men can share symptoms but require different screening questions, safeguards and differential diagnoses.
Peptide Program for Women
Explore appetite and weight concerns, metabolic health, energy, sleep, sexual wellness and life-stage considerations—with clear pregnancy and contraception safeguards.
Explore the Women’s ProgramPeptide Program for Men
Explore weight and cardiometabolic risk, sleep apnea, energy, recovery and sexual-health concerns—without confusing peptide therapy with testosterone care.
Explore the Men’s ProgramWhat Strong Evidence Looks Like
Large trials. Defined patients. Measured outcomes.
Trial averages are not promises; individual results, tolerability and eligibility vary.
Semaglutide at 68 weeks
Mean weight change in STEP 1 versus 2.4% with placebo, with lifestyle intervention, in adults with overweight or obesity without diabetes. Read the trial.
Tirzepatide at 72 weeks
Mean weight change across 5, 10 and 15 mg groups versus 3.1% with placebo in SURMOUNT-1. Gastrointestinal effects were most common. Read the trial.
The indication controls
Eligibility, contraindications, warnings, dosing and reproductive precautions come from the current product label—not social-media claims. Current tirzepatide label.
Physician-Crafted & Managed
Your program is a process, not a product list.
Listen
We define what changed, when it changed and what better would realistically look like.
Evaluate
Medical history, current medications, contraindications and labs when clinically indicated.
Decide together
Benefits, limits, alternatives, FDA status, cost and a clear reason to treat—or not treat.
Monitor
Follow-up for response, nutrition, tolerability, dose decisions and reasons to pause or stop.
Safety Before Sales
Some online peptide offers are a red flag.
Do not inject products labeled “research use only” or buy prescription drugs from an unverified source. FDA has reported dosing errors and adverse events with unapproved compounded GLP-1 products.
- No diagnosis or clinician evaluation
- No current medication review
- No explanation of FDA or compounding status
- No licensed pharmacy information
- No follow-up or adverse-effect plan
Primary Sources
Verify the clinical claims.
FDA: Concerns with unapproved GLP-1 drugs used for weight lossCompounding limits, dosing errors, fraudulent products and research-only ingredients.Open FDA guidance
STEP 1 randomized clinical trialOnce-weekly semaglutide in adults with overweight or obesity.Open PubMed record
SURMOUNT-1 randomized clinical trialTirzepatide for adults with obesity or overweight plus a weight-related complication.Open PubMed record
Evidence reviewed September 3, 2026 · Prepared under the Identity Aesthetics medical editorial standard. Educational content is not a diagnosis or individual medical advice.
Your Next StepBring us your questions.
Bring us your questions.
Leave with a real plan.
A clinical consultation determines whether a peptide-based medicine, another treatment or further evaluation best fits your health.